Shareholders are very likely to turn down the Michael Saylor pitch, Polymarket bettors are predicting. …
Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium
LONDON, April 21, 2026 (GLOBE NEWSWIRE) — Spur Therapeutics today announced the presentation of new …